[Possibilities of remaxol in prevention of toxic hepatitis during chemotherapy for cancer patients]

Autor:	V G, Cherenkov, A B, Petrov, T M, Vasil'eva, M M, Strozhenkov
Rok vydání:	2013
Předmět:	Adult Male Patient Selection Succinates Middle Aged Protective Agents Antioxidants Drug Administration Schedule Treatment Outcome Neoplasms Antineoplastic Combined Chemotherapy Protocols Phosphatidylcholines Humans Female Chemical and Drug Induced Liver Injury Aged
Zdroj:	Voprosy onkologii. 59(3)
ISSN:	0507-3758
Popis:	The effectiveness of planning polychemotherapy (PCT) for cancer patients depends on the functional state of the liver. The use of remaxol was studied in 100 patients with advanced forms of cancer (including breast cancer) in a preventive mode in comparison with the control group (100 patients, essentiale group of 40 patients) and in the process of PCT. Remaxol, compared with the control group, allowed reducing the frequency of drug hepatotoxicity by 30 +/- 3.7% and by 6.5 +/- 2.9% in comparison with the group of patients who received essentiale.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::ff95efcf965db98e609d256ad3be8d2f https://pubmed.ncbi.nlm.nih.gov/23909040 Zobrazit plný text záznamu